{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T08:56:59Z","timestamp":1729673819427,"version":"3.28.0"},"reference-count":16,"publisher":"IEEE","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1109\/bmei.2009.5302505","type":"proceedings-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T13:49:17Z","timestamp":1257428957000},"page":"1-4","source":"Crossref","is-referenced-by-count":0,"title":["A Monte Carlo Reliability Study of the Assessment of Chemotherapy Responses in Ovarian Cancer Treatment"],"prefix":"10.1109","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangzhou","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"263","reference":[{"year":"0","key":"15"},{"key":"16","article-title":"The expression of PKC ? inverted commasPKC ? and P-gp the expression of in ovarian cancer and their clinical significance","volume":"27","author":"xiong","year":"2006","journal-title":"Guangdong Medical Journal"},{"year":"0","key":"13"},{"year":"0","key":"14"},{"key":"11","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.E03-05-0279","article-title":"Gene Expression Patterns in Ovarian Carcinomas","volume":"14","author":"schaner","year":"2003","journal-title":"Molecular Biology of the Cell"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63306-8"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"year":"0","key":"2"},{"year":"0","key":"1"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204804"},{"key":"7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/gyno.1993.1292","article-title":"A proposal to use CA125 to evaluate activity of new neoplastic agents in ovarian cancer","volume":"51","author":"markman","year":"1993","journal-title":"Gynecol Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1008351216605","article-title":"Use of tumour markers in monitoring the course of ovarian cancer","volume":"10","author":"rustin","year":"1999","journal-title":"Ann Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity ofa monoclonal antibody with human ovarian carcinoma","volume":"68","author":"bast","year":"1981","journal-title":"J Clin Invest"},{"key":"4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1634\/theoncologist.2-1-6","article-title":"The role of CA-125 in the management of ovarian cancer","volume":"2","author":"markman","year":"1997","journal-title":"The Oncologist"},{"key":"9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125","volume":"14","author":"rustin","year":"1996","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00000421-198904000-00003","article-title":"CA125 values predictive of clinical response during second-line chemotherapy for epithelial ovarian cancer","volume":"12","author":"ng","year":"1989","journal-title":"American Journal of Clinical Oncology"}],"event":{"name":"2009 2nd International Conference on Biomedical Engineering and Informatics","start":{"date-parts":[[2009,10,17]]},"location":"Tianjin, China","end":{"date-parts":[[2009,10,19]]}},"container-title":["2009 2nd International Conference on Biomedical Engineering and Informatics"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx5\/5301643\/5301644\/05302505.pdf?arnumber=5302505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T08:52:46Z","timestamp":1590223966000},"score":1,"resource":{"primary":{"URL":"http:\/\/ieeexplore.ieee.org\/document\/5302505\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":16,"URL":"https:\/\/doi.org\/10.1109\/bmei.2009.5302505","relation":{},"subject":[],"published":{"date-parts":[[2009]]}}}